Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 249 entries
View as:

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

Phase: N/A Priority: Normal
NCT ID: NCT01021904 Org: User:
Start: 06/30/10 End: 12/31/14 Due: 12/31/15

Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02195141 Org: User:
Start: 01/31/14 End: 12/31/15 Due: 12/31/16

A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

Phase: N/A Priority: Normal
NCT ID: NCT02648841 Org: User:
Start: 07/31/15 End: 06/30/22 Due: 06/30/23

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03876886 Org: User:
Start: 02/22/19 End: 12/31/24 Due: 12/31/25

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Phase: N/A Priority: Normal
NCT ID: NCT05522894 Org: User:
Start: 10/01/22 End: 10/01/24 Due: 10/01/25

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05499715 Org: User:
Start: 09/30/22 End: 08/30/24 Due: 08/30/25

A Real-world Clinical Study of Kapok Initiative

Phase: N/A Priority: Normal
NCT ID: NCT04735991 Org: User:
Start: 05/08/20 End: 10/31/22 Due: 10/31/23

Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04511351 Org: User:
Start: 08/01/14 End: 12/30/20 Due: 12/30/21

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04509804 Org: User:
Start: 05/10/18 End: 01/01/20 Due: 01/01/21

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01180166 Org: User:
Start: 05/31/10 End: 09/30/13 Due: 09/30/14

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT05163652 Org: User:
Start: 12/18/21 End: 10/30/22 Due: 10/30/23

Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04348032 Org: User:
Start: 03/22/18 End: 06/30/22 Due: 06/30/23

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01431053 Org: User:
Start: 07/31/11 End: 07/31/14 Due: 07/31/15

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

Phase: N/A Priority: Normal
NCT ID: NCT02319187 Org: User:
Start: 12/31/14 End: 06/30/17 Due: 06/30/18

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Phase: N/A Priority: Normal
NCT ID: NCT00805597 Org: User:
Start: 06/30/08 End: 02/29/12 Due: 02/28/13

TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04888546 Org: User:
Start: 04/30/21 End: 07/30/24 Due: 07/30/25

Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04014465 Org: User:
Start: 02/01/19 End: 12/01/22 Due: 12/01/23

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02403544 Org: User:
Start: 09/30/13 End: 12/31/16 Due: 12/31/17

Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy

Phase: N/A Priority: Normal
NCT ID: NCT02448966 Org: User:
Start: 01/31/15 End: 12/31/19 Due: 12/31/20

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Phase: N/A Priority: Normal
NCT ID: NCT05149170 Org: User:
Start: 10/01/21 End: 09/30/24 Due: 09/30/25

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04749394 Org: User:
Start: 03/17/21 End: 06/30/25 Due: 06/30/26

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Phase: N/A Priority: Normal
NCT ID: NCT05441098 Org: User:
Start: 04/01/22 End: 12/31/22 Due: 12/31/23

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02961270 Org: User:
Start: 11/30/16 End: 08/31/18 Due: 08/31/19

Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT03816787 Org: User:
Start: 12/01/19 End: 05/29/21 Due: 05/29/22

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

Phase: N/A Priority: Normal
NCT ID: NCT02014805 Org: User:
Start: 07/31/13 End: 07/31/22 Due: 07/31/23